The indirect costs of cancer-related absenteeism in the workplace in Poland

Journal of Occupational and Environmental Medicine

Volumn 53, Issue 12, 2011, Pages 1472-1477

  Macioch, Tomasz ^a   Hermanowski, Tomasz ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ABSENTEEISM; ADULT; ARTICLE; CANCER PATIENT; CANCER REGISTRY; COST; DISABILITY; EMPLOYEE; FEMALE; HUMAN; MALE; MEDICAL LEAVE; POLAND; PRODUCTIVITY; WORKPLACE;

EID: 84856415013     PISSN: 10762752     EISSN: 15365948     Source Type: Journal    
DOI: 10.1097/JOM.0b013e3182398dc7     Document Type: Article

References (20)

1. World Health Organization. The Global Burden of Disease: 2004 Update. Geneva, Switzerland: World Health Organization; 2008. Available at: http://www.who.int/healthinfo/global-burden-disease/projections/en/index.html. Accessed March 29, 2011.
2. Rutkowska L. Central Statistical Office of Poland Demographic Surveys Division. Life expectancy tables of Poland 2009. Warsaw, Poland: CSO, Statistical Publishing Establishment. Available at: http://www.stat.gov. pl/cps/rde/xbcr/gus/PUBL-lud-trwanie-zycia-2009.pdf. Accessed March 29, 2011.
3. Polish National Cancer Database. Available at: http://epid.coi.waw.pl/ krn. Accessed March 29, 2011.
4. American Cancer Society. Cancer Facts & Figures 2009. Atlanta, GA: American Cancer Society; 2009.
5. Wilking N, Jönsson B. A Pan-European Comparison Regarding Patient Access to Cancer Drugs. Stockholm, Sweden: Karolinska Institutet in collaboration with Stockholm School of Economics; 2005. Available at: http://ki.se/content/1/c4/33/52/Cancer-Report.pdf. Accessed March 29, 2011.
6. OECD Health Data 2010. Available at: http://www.oecd.org/topic/0, 3699, en-2649-37407-1-1-1-1-37407, 00.html. Accessed March 29, 2011.
7. NHF data. Available at: http://www.nfz.gov. pl/new/index.php?katnr= 3&dzialnr =11&artnr=4137. Accessed March 29, 2011.
8. EUROCARE-4 data. Available at: http://www.eurocare.it/Portals/0/CDEU4/ Index.htm. Accessed March 29, 2011.
9. Liljas B. How to calculate indirect costs in economic evaluations. Pharmacoeconomics. 1998;13(Pt 1):1-7.
10. Rice DP, Hodgson TA, Kopstein AN. The economic costs of illness: a replication and update. Health Care Financ Rev. 1985;7:61-80. (Pubitemid 17008319)
11. Max W, Rice DP, Sung HY, Michel M, Breuer W, Zhang X. The economic burden of prostate cancer, California, 1998. Cancer. 2002;94:2906-2913. (Pubitemid 34547689)
12. Max W, Rice DP, Sung HY, Michel M, Breuer W, Zhang X. The economic burden of gynecologic cancers in California, 1998. Gynecol Oncol. 2003;88:96-103. (Pubitemid 36263365)
13. Insinga RP. Annual productivity costs due to cervical cancer mortality in the United States. Womens Health Issues. 2006;16:236-242. (Pubitemid 44572797)
14. Glied S. Estimating the indirect cost of illness: an assessment of the forgone earnings approach. Am J Public Health. 1996;86:1723-1728.
15. de Lima Lopes G Jr, Gluck S. Health economics in the Journal of Clinical Oncology and an evaluation of the indirect costs and benefits associated with adjuvant trastuzumab. J Clin Oncol. 2007;25:3382-3383; author reply 3383. (Pubitemid 47325629)
16. Dmochowska H, ed. Central Statistical Office of Poland. Concise Statistical Yearbook of Poland. Warsaw, Poland: CSO, Statistical Publishing Establishment; 2010. Available at: http://www.stat.gov. pl/cps/rde/xbcr/gus/ PUBL-oz-maly-rocznik-statystyczny-2010.pdf. Accessed March 29, 2011.
17. Zgierska A, Cacko M, Cendrowska A, Derucka K, Matuszewska-Kafarska E. Central Statistical Office of Poland Labour Division. Labour Force Survey in Poland IV Quarter 2009. Warsaw, Poland: CSO, Statistical Publishing Establishment; 2010. Available at: http://www.stat.gov. pl/gus/5840-3044-PLK- HTML.htm. Accessed March 29, 2011.
18. Pukkala E, Martinsen JI, Lynge E, et al. Occupation and cancer-follow-up of 15 million people in five Nordic countries. Acta Oncol. 2009;48:646-790.
19. Agency for Health Technology Assessment. Guidelines for Conducting Health Technology Assessment (HTA). Warsaw, Poland: Agency for Health Technology Assessment; 2009. Available at: http://www.aotm.gov. pl/assets/files/wytyczne- hta/2009/09.06.29-wytyczne-HTA-eng-MS.pdf. Accessed March 29, 2011.
20. Schultz AB, Chen CY, Edington DW. The cost and impact of health conditions on presenteeism to employers: a review of the literature. Pharmacoeconomics. 2009;27:365-378.